Lupin to boost complex generics in US, EU; eyes chronic growth in India
Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…
Indian Pharma Market Reaches Rs 19,083 Crore In December, Check Out Top Performing Brands
New Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This marks a 7.68% increase compared to the previous…